515 related articles for article (PubMed ID: 9339933)
21. Predictors of nonsentinel lymph node metastasis in breast cancer patients.
Sachdev U; Murphy K; Derzie A; Jaffer S; Bleiweiss IJ; Brower S
Am J Surg; 2002 Mar; 183(3):213-7. PubMed ID: 11943113
[TBL] [Abstract][Full Text] [Related]
22. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
23. [Sentinel lymph node biosy in surgical treatment of breast carcinoma: prospective study].
Gatĕk J; Bakala J; Dudesek B; Duben J; Hnátek L; Dvorácková J
Ceska Gynekol; 2003 Jan; 68(1):6-10. PubMed ID: 12708107
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
25. Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer.
Hsu GC; Ku CH; Yu JC; Hsieh CB; Yu CP; Chao TY
Clin Cancer Res; 2006 Jun; 12(12):3746-53. PubMed ID: 16778102
[TBL] [Abstract][Full Text] [Related]
26. Validation of Breast Cancer Models for Predicting the Nonsentinel Lymph Node Metastasis After a Positive Sentinel Lymph Node Biopsy in a Chinese Population.
Wu P; Zhao K; Liang Y; Ye W; Liu Z; Liang C
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785032. PubMed ID: 30033828
[TBL] [Abstract][Full Text] [Related]
27. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
28. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.
Schreiber RH; Pendas S; Ku NN; Reintgen DS; Shons AR; Berman C; Boulware D; Cox CE
Ann Surg Oncol; 1999; 6(1):95-101. PubMed ID: 10030421
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
30. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
Giuliano AE; Kirgan DM; Guenther JM; Morton DL
Ann Surg; 1994 Sep; 220(3):391-8; discussion 398-401. PubMed ID: 8092905
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma.
Sabel MS; Zhang P; Barnwell JM; Winston JS; Hurd TC; Edge SB
J Surg Oncol; 2001 Aug; 77(4):243-6. PubMed ID: 11473372
[TBL] [Abstract][Full Text] [Related]
33. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.
Cserni G; Bianchi S; Vezzosi V; Peterse H; Sapino A; Arisio R; Reiner-Concin A; Regitnig P; Bellocq JP; Marin C; Bori R; Penuela JM; Iturriagagoitia AC
J Clin Pathol; 2006 May; 59(5):518-22. PubMed ID: 16497870
[TBL] [Abstract][Full Text] [Related]
34. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.
Turner RR; Ollila DW; Stern S; Giuliano AE
Am J Surg Pathol; 1999 Mar; 23(3):263-7. PubMed ID: 10078915
[TBL] [Abstract][Full Text] [Related]
35. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node.
Turner RR; Chu KU; Qi K; Botnick LE; Hansen NM; Glass EC; Giuliano AE
Cancer; 2000 Aug; 89(3):574-81. PubMed ID: 10931456
[TBL] [Abstract][Full Text] [Related]
36. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
37. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
Haigh PI; Hansen NM; Qi K; Giuliano AE
Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
[TBL] [Abstract][Full Text] [Related]
38. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
39. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
40. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
